Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Treasury Shares (2023 - 2024)

Historic Treasury Shares for Corvus Pharmaceuticals (CRVS) over the last 2 years, with Q3 2024 value amounting to $400000.0.

  • Corvus Pharmaceuticals' Treasury Shares changed N/A to $400000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $400000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Corvus Pharmaceuticals reported Treasury Shares of $400000.0 as of Q3 2024.
  • Corvus Pharmaceuticals' Treasury Shares' 5-year high stood at $400000.0 during Q4 2023, with a 5-year trough of $400000.0 in Q4 2023.